Showing results (1-10 of 652) with videos related to
Sort By:
Pageof 66
Biochemical Society Transactions|March 7, 2019
Caught in the act: LRRK2 in exosomesShijie Wang, Andrew B WestEbiomedicine|June 24, 2019
Proteomic analysis of urinary extracellular vesicles reveal biomarkers for neurologic diseaseShijie Wang, Kyoko Kojima, James A Mobley, et al.NPJ Parkinson'S Disease|December 10, 2020
Exosome markers of LRRK2 kinase inhibitionShijie Wang, Kaela Kelly, Jonathan M Brotchie, et al.Acta Neuropathologica Communications|November 24, 2017
Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriersShijie Wang, Zhiyong Liu, Tao Ye, et al.Experimental Neurology|July 27, 2018
The G2019S mutation in LRRK2 imparts resiliency to kinase inhibitionKaela Kelly, Shijie Wang, Ravindra Boddu, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
Ten years and counting: moving leucine-rich repeat kinase 2 inhibitors to the clinicAndrew B WestExperimental Neurology|August 3, 2017
Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson diseaseAndrew B WestGenome Medicine|October 21, 2017
Breathing new life into an old target: pulmonary disease drugs for Parkinson's disease therapyHisham Abdelmotilib, Andrew B WestFrontiers in Neuroscience|September 9, 2020
Pharmacodynamic Biomarkers for Emerging LRRK2 TherapeuticsKaela Kelly, Andrew B WestBiochimica Et Biophysica Acta. Proteins and Proteomics|December 13, 2016
The dual enzyme LRRK2 hydrolyzes GTP in both its GTPase and kinase domains in vitroZhiyong Liu, Andrew B WestPageof 66